Molecular on-off switches for cancer and autoimmunity defined
October 1st, 2010 - 2:40 pm ICT by ANIWashington, Oct 1 (ANI): Scientists from the Institute for Advanced Studies in New Jersey are examining how oncogenes and tumour suppressor genes handle cellular stress, and said that each of these opposing systems could be potent drug targets in the effort to stop cancer.
In addition, their hypothesis provides new insights into what contributes to immunological disorders such as chronic inflammation and autoimmune diseases.
“Among those experiments are the synthesis of new drugs to inhibit pathways that could change the course of a disease,” said Arnold Levine, Ph.D., co-author of the study from the Institute for Advanced Study in Princeton, New Jersey.
The research specifically examines the roles of the p53 tumour suppressor and the oncogene, NF-kappaB.
The p53 suppressor limits the consequences of stress by initiating cell death and promoting metabolic patterns in the cell. The oncogene NF-kappaB on the other hand, promotes cell division resulting in the synthesis of substrates for cell division.
These two opposite cellular responses cannot function in the same cell at the same time. So Levine and colleagues speculate that drugs could be developed to take advantage of the fact that if one factor is activated, the other is rendered inactive.
“Our cells use the p53 and NF-kappaB pathways to respond to cellular stress: one controls cancer, the other immunity. If they get out of balance, we’re in trouble.,” said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal.
“Thanks to this work we can start restore the balance by means of new drugs.”
The report is published in the October 2010 print issue of The FASEB Journal. (ANI)
- Key pathway implicated in progression of childhood cancer found - Sep 19, 2010
- Scientists complete whole-exome sequencing of skin cancer - Apr 16, 2011
- Restoring gene may slow spread of advanced lung tumours - Nov 25, 2010
- How red wine and green tea can prevent prostate cancer growth - Jun 10, 2010
- Most common adult brain cancer associated with gene deletion - Dec 23, 2010
- Protein aggregation plays significant role in cancer development - Mar 30, 2011
- Genetic mutation linked to premature birth identified - Feb 02, 2010
- Secrets of common virus that can cause cancer decoded - Dec 16, 2010
- Men, women's immune systems respond differently to post-traumatic stress disorder - Apr 27, 2011
- New drug shrinks cancer, with few side effects - Apr 07, 2011
- New 'Nanobody' agents help identify patients who will benefit from breast cancer drugs - Apr 12, 2011
- Combo therapy may overcome Herceptin-resistant breast cancer - Mar 14, 2011
- Small molecules 'could block cell proliferation in cancerous human tumor' - Apr 14, 2011
- Mice study shows slight changes in 2 genes launches breast cancer development - May 13, 2010
- DNA damage can help protect the body from infection - Apr 01, 2011
Tags: arnold levine, autoimmune diseases, cancer and autoimmunity, cell death, cellular responses, chronic inflammation, co author, consequences of stress, drug targets, faseb journal, gerald weissmann, new drugs, new insights, nf, oncogene, oncogenes, p53, potent drug, princeton new jersey, tumour suppressor genes